{"id":"https://openalex.org/W1973197771","doi":"https://doi.org/10.1586/14737175.8.1.19","title":"Depersonalization disorder: pharmacological approaches","display_name":"Depersonalization disorder: pharmacological approaches","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W1973197771","doi":"https://doi.org/10.1586/14737175.8.1.19","mag":"1973197771","pmid":"https://pubmed.ncbi.nlm.nih.gov/18088198"},"language":"en","primary_location":{"id":"doi:10.1586/14737175.8.1.19","doi":"https://doi.org/10.1586/14737175.8.1.19","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737175.8.1.19","pdf_url":null,"source":{"id":"https://openalex.org/S1502225","display_name":"Expert Review of Neurotherapeutics","issn_l":"1473-7175","issn":["1473-7175","1744-8360"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Neurotherapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973197771"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105217087","display_name":"Mauricio Sierra","orcid":"https://orcid.org/0000-0001-8433-2560","observed_orcids":["https://orcid.org/0000-0001-8433-2560"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mauricio Sierra","raw_affiliation_strings":["Depersonalization Research Unit, Institute of Psychiatry, King\u2019s College, Section of Neuropsychiatry P068, De Crespigny Park, Denmark Hill, London SE5 8AF, UK","Depersonalization Research Unit, Institute of Psychiatry, King\u2019s College, Section of Neuropsychiatry P068, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. m.sierra-siegert@iop.kcl.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Depersonalization Research Unit, Institute of Psychiatry, King\u2019s College, Section of Neuropsychiatry P068, De Crespigny Park, Denmark Hill, London SE5 8AF, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Depersonalization Research Unit, Institute of Psychiatry, King\u2019s College, Section of Neuropsychiatry P068, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. m.sierra-siegert@iop.kcl.ac.uk","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105217087"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":null,"apc_paid":null,"fwci":0.5978,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.48185484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"8","issue":"1","first_page":"19","last_page":"26"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11334","display_name":"Psychosomatic Disorders and Their Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11334","display_name":"Psychosomatic Disorders and Their Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depersonalization-derealization-disorder","display_name":"depersonalization disorder","score":1.0},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.8970000147819519},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9760000109672546},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.9860000014305115},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.5830000042915344},{"id":"https://openalex.org/keywords/stress-response","display_name":"stress response","score":0.7699999809265137},{"id":"https://openalex.org/keywords/limbic-system","display_name":"limbic system","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779229956","wikidata":"https://www.wikidata.org/wiki/Q83177","display_name":"Depersonalization","level":4,"score":0.6122114062309265},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5735529065132141},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4927964508533478},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.46801766753196716},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.466068297624588},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4604319930076599},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4500090777873993},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.43562906980514526},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.34694352746009827},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3248642683029175},{"id":"https://openalex.org/C143916079","wikidata":"https://www.wikidata.org/wiki/Q2629248","display_name":"Burnout","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C88519622","wikidata":"https://www.wikidata.org/wiki/Q776232","display_name":"Emotional exhaustion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003861","descriptor_name":"Depersonalization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003861","descriptor_name":"Depersonalization","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1586/14737175.8.1.19","doi":"https://doi.org/10.1586/14737175.8.1.19","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737175.8.1.19","pdf_url":null,"source":{"id":"https://openalex.org/S1502225","display_name":"Expert Review of Neurotherapeutics","issn_l":"1473-7175","issn":["1473-7175","1744-8360"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Neurotherapeutics","raw_type":"journal-article"},{"id":"pmid:18088198","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18088198","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of neurotherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/154eae7b-119a-4b79-8fbc-66aa2c0dcadb","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/154eae7b-119a-4b79-8fbc-66aa2c0dcadb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sierra-Siegert, M 2008, 'Depersonalization disorder : pharmacological approaches', Expert Review of Neurotherapeutics, vol. 8, no. 1, pp. 19-26. https://doi.org/10.1586/14737175.8.1.19","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W110894270","https://openalex.org/W1966980165","https://openalex.org/W1972720308","https://openalex.org/W1975319710","https://openalex.org/W1979338157","https://openalex.org/W1979605257","https://openalex.org/W1980079555","https://openalex.org/W1984908695","https://openalex.org/W1984929847","https://openalex.org/W1988459373","https://openalex.org/W1988538582","https://openalex.org/W1990256375","https://openalex.org/W1990882430","https://openalex.org/W2001268486","https://openalex.org/W2001749931","https://openalex.org/W2007881724","https://openalex.org/W2009952140","https://openalex.org/W2012988989","https://openalex.org/W2013019301","https://openalex.org/W2016158375","https://openalex.org/W2021747445","https://openalex.org/W2024065110","https://openalex.org/W2028884770","https://openalex.org/W2030931774","https://openalex.org/W2032643119","https://openalex.org/W2049627162","https://openalex.org/W2051030173","https://openalex.org/W2054798006","https://openalex.org/W2063204937","https://openalex.org/W2068429709","https://openalex.org/W2074099337","https://openalex.org/W2074437114","https://openalex.org/W2084210364","https://openalex.org/W2084456809","https://openalex.org/W2085153801","https://openalex.org/W2086593869","https://openalex.org/W2092440907","https://openalex.org/W2099741389","https://openalex.org/W2101776442","https://openalex.org/W2104110447","https://openalex.org/W2108600828","https://openalex.org/W2109448712","https://openalex.org/W2109699325","https://openalex.org/W2121611952","https://openalex.org/W2127335096","https://openalex.org/W2129026101","https://openalex.org/W2131066767","https://openalex.org/W2134541433","https://openalex.org/W2135884966","https://openalex.org/W2137830721","https://openalex.org/W2145998697","https://openalex.org/W2148208755","https://openalex.org/W2149110258","https://openalex.org/W2163186446","https://openalex.org/W2165816295","https://openalex.org/W2165981166","https://openalex.org/W2171052465","https://openalex.org/W2317196251","https://openalex.org/W2415902730","https://openalex.org/W2430040446","https://openalex.org/W2469521892","https://openalex.org/W2469775645","https://openalex.org/W4302325808"],"related_works":["https://openalex.org/W2085153801","https://openalex.org/W2105914303","https://openalex.org/W2013019301","https://openalex.org/W2066166897","https://openalex.org/W4360617344","https://openalex.org/W2125651018","https://openalex.org/W79809242","https://openalex.org/W2415737661","https://openalex.org/W2134541433"],"abstract_inverted_index":{"Depersonalization":[0,91],"disorder":[1],"(DPD)":[2],"is":[3,51,198],"a":[4,10,44,62,84,93,120,140,159,173,201],"chronic":[5,88],"and":[6,18,77,89,101,152],"distressing":[7],"condition":[8,50,94],"with":[9,43,75,192,214,223,231],"prevalence":[11],"in":[12,23,41,129,156,200,212,221,251],"the":[13,24,49,66,168,207,232,252,255],"general":[14],"population":[15],"between":[16],"0.8":[17],"2%.":[19],"Several":[20],"neurobiological":[21],"studies":[22,135,143],"last":[25],"decade":[26],"have":[27,31,111,127],"shown":[28],"that":[29,48,145,185],"patients":[30,222],"suppressed":[32],"limbic":[33],"activation":[34],"to":[35,59,114,218,242,246],"emotional":[36],"stimuli.":[37],"Such":[38,61],"findings":[39],"are":[40,136,154,244],"line":[42,230],"model":[45,234],"which":[46,96,103],"suggests":[47],"generated":[52],"by":[53],"an":[54,189],"anxiety-triggered,":[55],"'hard-wired'":[56],"inhibitory":[57,249],"response":[58,85],"threat.":[60],"mechanism":[63],"would":[64,86],"ensure":[65],"preservation":[67],"of":[68,116,124,142,161,165,170,204,209,226,235,240,254],"adaptive":[69],"behavior,":[70],"during":[71],"situations":[72],"normally":[73],"associated":[74],"overwhelming":[76],"potentially":[78],"disorganizing":[79],"anxiety.":[80,228],"In":[81,163,229],"DPD,":[82],"such":[83,106,149],"become":[87],"dysfunctional.":[90],"remains":[92],"for":[95,102],"no":[97],"definitive":[98],"treatment":[99,126,191],"exists,":[100],"conventional":[104],"medications,":[105],"as":[107,150,172,188],"antidepressants":[108],"or":[109],"antipsychotics,":[110],"been":[112,178],"found":[113,179],"be":[115,219],"little":[117],"value.":[118],"Fortunately,":[119],"few":[121],"promising":[122],"lines":[123],"pharmacological":[125],"emerged":[128],"recent":[130],"years,":[131],"although":[132],"more":[133],"rigorous":[134],"needed.":[137],"For":[138],"example,":[139],"number":[141,203],"suggest":[144,184],"opioid":[146],"receptor":[147],"antagonists":[148],"naltrexone":[151],"naloxone":[153],"useful":[155],"at":[157],"least":[158],"subgroup":[160],"patients.":[162,205],"spite":[164],"initial":[166],"expectations,":[167],"use":[169,187,208],"lamotrigine":[171],"sole":[174],"medication":[175],"has":[176],"not":[177],"useful.":[180],"However,":[181],"open-label":[182],"trials":[183],"its":[186],"add-on":[190],"selective":[193],"serotonin":[194],"reuptake":[195],"inhibitors":[196],"(SSRIs)":[197],"beneficial":[199,220],"substantial":[202],"Similarly,":[206],"clonazepam,":[210],"particularly":[211],"conjunction":[213],"SSRI":[215],"antidepressants,":[216],"appears":[217],"high":[224],"levels":[225],"background":[227],"stress-related":[233],"depersonalization,":[236],"those":[237],"neurotransmitter":[238],"systems":[239],"relevance":[241],"depersonalization":[243],"known":[245],"play":[247],"important":[248],"roles":[250],"regulation":[253],"stress":[256],"response.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973197771","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
